PDL BioPharma Inc. buy shadow
Start price
06.10.20
/
50%
€2.11
Target price
04.11.21
-
Performance (%)
5.22%
End price
05.11.21
-
Summary
This prediction is currently being closed. The BUY prediction by shadow shows slight gains of 5.22%. shadow has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| PDL BioPharma Inc. | - | - | - | - |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
According to shadow what are the pros and cons of PDL BioPharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
High dividend yield expected
Valuable balance sheet
Good culture
Innovative
Revenue growth >5% per year expected
Capable Management
Differentiated customer and product portfolio
Future proof or reliable business model
Fair valuation
ROE higher than 10% per year
Cons
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
Bad rating
Little Investments for future growth
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Significant cyclical dependencies
Little known brand
Increased challenges to pay loans and raise capital
Few uniques
Below average Marketposition
Comments by shadow for this prediction
In the thread PDL BioPharma Inc. diskutieren
Buy PDL BioPharma Inc.
In the thread Trading PDL BioPharma Inc.
Die von shadow gewählte maximale Laufzeit wurde überschritten